The FMR1 promoter in FXS ESCs was fully methylated as evidenced by a methylation-sensitive qPCR assay which provides a quantitative measure of bulk methylation at HpaII sites in the FMR1 promoter (Fig. 1C). This evidence concerns the gene FMR1 and fragile X syndrome.